These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6698886)

  • 21. [New derivatives of carminomycin and rubomycin].
    Olsuf'eva EN; Aleksandrova LG; Rozynov BV; Potapova NP
    Antibiot Khimioter; 1988 Oct; 33(10):729-35. PubMed ID: 3214206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Minor components from the carminomycin complex].
    Zbarskiĭ VB; Potapova NP; Olsuf'eva EN; Rubasheva LM; Brazhnikova MG
    Antibiotiki; 1980 Jul; 25(7):492-5. PubMed ID: 6250461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microbial conversion of daunomycin, carminomycin I and feudomycin A to adriamycin.
    Oki T; Takatsuki Y; Tobe H; Yoshimoto A; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1981 Sep; 34(9):1229-31. PubMed ID: 7328065
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapy of acute leukemia: contribution of the new anthracyclinic drugs].
    Lambertenghi-Deliliers G; Colajori E; Annaloro C; Polli EE
    Recenti Prog Med; 1985; 76(7-8):392-7. PubMed ID: 3906794
    [No Abstract]   [Full Text] [Related]  

  • 25. [Synthesis and properties of the N-acyl derivatives of carminomycin and rubomycin].
    Olsuf'eva EN; Povarov LS
    Antibiotiki; 1980 May; 25(5):333-8. PubMed ID: 7387126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Letter: Total synthesis of (+/-)-daunomycinone and (+/-)-carminomycinone.
    Kende AS; Tsay YG; Mills JE
    J Am Chem Soc; 1976 Mar; 98(7):1967-9. PubMed ID: 1254856
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cytostatic action of semisynthetic derivatives of carminomycin].
    Volkolupova OP; Makukho LV
    Antibiotiki; 1982 Feb; 27(2):145-7. PubMed ID: 7065650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Semisynthetic derivatives of daunorubicin and carminomycin: inhibition of DNA synthesis after intravenous administration to mice].
    Reznikova MI; Dudnik IuV
    Antibiot Khimioter; 1988 Sep; 33(9):653-7. PubMed ID: 3218988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Current status of clinical results of new antitumor drugs].
    Ogawa M
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):179-88. PubMed ID: 3918502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives.
    Young CW; Raymond V
    Cancer Treat Rep; 1986 Jan; 70(1):51-63. PubMed ID: 2935251
    [No Abstract]   [Full Text] [Related]  

  • 31. ["Chimeric" antibiotics, daunorubicin and its analogs N-acylated with bruneomycin (Streptonigrin)].
    Tolstikov VV; Kozlova NV; Iartseva IV; Preobrazhenskaia MN
    Bioorg Khim; 1989 Feb; 15(2):277-80. PubMed ID: 2500939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New morpholino anthracyclines, MX, MX2, and MY5.
    Umezawa H; Nakajima S; Kawai H; Komeshima N; Yoshimoto H; Urata T; Odagawa A; Otsuki N; Tatsuta K; Otake N
    J Antibiot (Tokyo); 1987 Jul; 40(7):1058-61. PubMed ID: 3476481
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antitumor antibiotics of the anthracycline series and their semisynthetic derivatives].
    Povarov LS
    Antibiotiki; 1977 Jul; 22(7):653-67. PubMed ID: 883809
    [No Abstract]   [Full Text] [Related]  

  • 34. [Acute toxicity of the N-acyl derivatives of carminomycin and rubomycin].
    Shepelevtsev NG; Gol'dberg LE; Olsuf'eva EN; Povarov LS
    Antibiotiki; 1982 Jan; 27(1):57-61. PubMed ID: 7059147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microbial conversion of daunorubicin into N-acetyl-13(S)-dihydrodaunomycin and bisanhydro-13-dihydrodaunomycinone.
    Dornberger K; Hübener R; Ihn W; Thrum H; Radics L
    J Antibiot (Tokyo); 1985 Sep; 38(9):1219-25. PubMed ID: 4066504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor antibiotic carminomycin.
    Gause GF
    Z Allg Mikrobiol; 1980; 20(3):219-25. PubMed ID: 6158803
    [No Abstract]   [Full Text] [Related]  

  • 37. Microbial conversion of epsilon-pyrromycinone and epsilon-isorhodomycinone to 1-hydroxy-13-dihydrodaunomcyin and N-formyl-1-hydroxy-13-dihydrodaunomycin and their bioactivities.
    Yoshimoto A; Matsuzawa Y; Oki T; Naganawa H; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1980 Oct; 33(10):1150-7. PubMed ID: 7451366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Changes in the spatial organization of DNA molecules induced by anthracycline antibiotics].
    Salianov VI; Evdokimov IuM; Berg G
    Antibiotiki; 1982 Dec; 27(12):38-42. PubMed ID: 6962685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new anthracycline antibiotic SN-706.
    Kimura K; Koyama T; Nakayama S; Tamura K; Miyata N; Kawanishi G
    J Antibiot (Tokyo); 1988 Dec; 41(12):1918-21. PubMed ID: 3209485
    [No Abstract]   [Full Text] [Related]  

  • 40. [Synthesis and antitumor action of 14-N-substituted derivatives of rubomycin and karminomycin].
    Olsuf'eva EN; Povarov LS; Salimova EI; Volkolupova OP; Makukho LV
    Antibiot Med Biotekhnol; 1987 Apr; 32(4):254-9. PubMed ID: 3631931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.